Saitama, Japan

Fujimura Yasuo

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fujimura Yasuo. Retrieved from https://idiyas.com/inventor/fujimura-yasuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fujimura Yasuo: Innovator in Pharmaceutical Chemistry

Introduction

Fujimura Yasuo is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrazoloindazole derivatives. His research has implications for the development of new medicinal compounds.

Latest Patents

Fujimura holds a patent for "Pyrazoloindazole derivatives and pharmaceutical composition containing pyrazoloindazole derivatives." This patent describes compounds that exhibit bronchodilating action, making them useful as a medicine. The specific formula includes various functional groups that enhance the therapeutic potential of these compounds.

Career Highlights

Fujimura Yasuo is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work there has focused on developing innovative solutions to medical challenges, particularly in respiratory health.

Collaborations

Fujimura has collaborated with esteemed colleagues such as Yasuyuki Shiraki and Minoru Shindo. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Fujimura Yasuo's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the field. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…